A study shows women are at greater risk of heart diseases, strokes and diabetes before reaching menopause rather than afterward. Lead author of the study was Dr. Mark DeBoer, a researcher at University of Virginia School of Medicine, Charlottesville.
Silicon Valley based iHealth Labs Inc introducing a mobile diabetes management application and clinical practice tool which increases the real-time connection between patients visits to certified diabetes educators (CDEs). The tool is named as "iGluco Pro" and the tool helps certified diabetes educators (CDEs) to maintain the real-time connection with their patients. The tool helps in sharing and monitoring information on
Researchers from the Technical University of Munich, Germany says better treatment for diabetes and obesity can be developed after understanding how the brain regulates sugar uptake as the brain is the largest consumer of the sugar. Recent experiments show that sugar uptake in the brain is not passive. Astrocytes are the most common cells in the brain. Receptors on astrocytes play important role in deciding amount of sugar required for the brain. Dr. Cristina Garcia-Caceres from Helmholtz Diabetes Center was the lead author of the study and the study findings were published in the journal Cell.
Danish Novo Nordisk confirmed that Tresiba (insulin degludec) drug was approved by the Scottish Medicines Consortium (SMC) to treat Scottish NHS diabetes patients. The approval is for adults, adolescent patients and children over the age of 1 year.
A study done by lead author Chika Horikawa, Niigata University, Japan shows that hearing damage (damage to the auditory system) is linked to diabetes. Study results suggest hearing test should be included in the management of type 2 diabetes (T2D). About 15% of the adults are suffering from hearing problems. Blood vessels will be damaged due to high blood sugar levels. An individual should consult an audiologist specialized in hearing if one faces the problem with hearing. The study results were published in the Journal of Clinical Endocrinology & Metabolism (JCEM).
Blood cells are made by "hematopoietic" stem cells in bone marrow, which is a soft and spongy tissue inside the bones. By transplanting bone marrow stem cell safely, autoimmune diseases can be cured in individuals suffering from those diseases. Autoimmune diseases force immune system to attack the body. Examples for autoimmune diseases are diabetes, lupus, arthritis and multiple sclerosis. With the new technique developed by the researchers from Stanford University, it is possible to remove a defective immune system from the body. Researchers developed two different antibodies whose job is to identify and flag malfunctioning blood stem cells as "waste disposal" cells and finally destroy them. Researchers successfully conducted experiments with animals and say the technique can be used in humans too. The research was published in the journal Science Translational Medicine.
Non-healing chronic foot wounds are one of major complication to individuals suffering from diabetes. Researchers successfully reprogrammed and developed induced pluripotent stem cells (iPSCs) from the cells taken from the skin of diabetic foot ulcers. iPSCs can be developed into a variety of cell types to create disease models and treatments. They can be used to treat non-healing chronic foot wounds or foot ulcers. The study was done by Dr. Behzad Gerami-Naini, PhD.
A study done by Dr. Samuel A Eryd, University of Gothenburg, Sweden shows type ii diabetes (T2D) individuals with systolic blood pressure lower than 140 mm Hg are at lower risk of cardiovascular events. The study shows no "J" shaped relation between blood pressure (BP) and complications except for heart failure and total mortality. The research findings were published in BMJ.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.